The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult
Matthew Lewis1, Marlon Rosenbaum2
1Herbert Irving Pavilion, 161 Fort Washington Ave Suite 627, New York, NY, 10032, USA. ml3329@cumc.columbia.edu.
Insights
Hypoplastic left heart syndrome (HLHS) patients now survive to adulthood but face lifelong complications from single-ventricle palliation. Recognizing and addressing these challenges is crucial for improving long-term outcomes and quality of life.
Area of Science:
- Adult congenital heart disease
- Single-ventricle palliation
- Hypoplastic left heart syndrome (HLHS)
Background:
- Hypoplastic left heart syndrome (HLHS) is a complex congenital heart defect characterized by underdevelopment of the left heart.
- Historically fatal in infancy, modern surgical techniques now enable HLHS patients to reach adulthood.
- Despite improved survival, significant long-term morbidity and mortality persist in the adult HLHS population.
Purpose of the Study:
- To review common sources of morbidity and mortality in adult patients with Hypoplastic left heart syndrome (HLHS).
- To identify areas requiring further research to improve the prognosis and quality of life for this growing patient group.
- To emphasize the importance of understanding lifelong challenges associated with single-ventricle repair.
Main Methods:
- This review synthesizes current literature on the long-term outcomes of Hypoplastic left heart syndrome (HLHS).
- Analysis focuses on complications arising from single-ventricle palliation, particularly the Fontan procedure.
- Identifies patient-specific risks and areas for future clinical investigation.
Main Results:
- Adults with palliated Hypoplastic left heart syndrome (HLHS) experience significant lifelong morbidity due to elevated systemic venous pressures post-Fontan procedure.
- Downstream organ dysfunction is a major concern, influencing management and organ allocation decisions.
- Patients with a morphologic systemic right ventricle, common in HLHS, may face even higher risks.
Conclusions:
- The growing adult Hypoplastic left heart syndrome (HLHS) population requires increased recognition of their unique lifelong health challenges.
- A collaborative approach between patients and healthcare providers is essential to address clinical uncertainties.
- Continued research and coordinated care are vital for enhancing patient prognosis and quality of life.
Purpose Of Review:
Hypoplastic left heart syndrome (HLHS) is characterized by underdevelopment of the mitral valve, left ventricle, and aorta and is ultimately palliated with a single-ventricle repair. Universally fatal in infancy prior to the advent of modern surgical techniques, the majority of HLHS patients will now reach adulthood. However, despite improvements in early survival, the HLHS population continues to face significant morbidity and early mortality. This review delineates common sources of patient morbidity and highlights areas in need of additional research for this growing segment of the adult congenital heart disease population.
Recent Findings:
It has become increasingly clear that palliated adult single ventricle patients, like those with HLHS, face significant life-long morbidity from elevated systemic venous pressures as a consequence of the Fontan procedure. Downstream organ dysfunction secondary to elevated Fontan pressures has the potential to significantly impact long-term management decisions, including strategies of organ allocation. Because of the presence of a morphologic systemic right ventricle, HLHS patients may be at even higher risk than other adult patients with a Fontan. Because the adult HLHS population continues to grow, recognition of common sources of patient morbidity and mortality is becoming increasingly important. A coordinated effort between patients and providers is necessary to address the many remaining areas of clinical uncertainty to help ensure continued improvement in patient prognosis and quality of life.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure III: Clinical Manifestations
Cardiopulmonary Resuscitation I: Adult
Mitral Stenosis I: Introduction
Pathophysiology of Heart Failure


